Swaraj Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 2.00 M
- Revenue Growth -13.93%
- Profit Growth -57.58%
- Ebitda -8.83%
- Net Worth -100.50%
- Total Assets 4.50%
About Swaraj Formulations
Swaraj Formulations Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2012 and has a history of 12 years and 11 months. Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 M.
Raj Kandhari, Pooja Kandhari, and Mathew Joseph serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85190MH2012PTC228535
- Company No.
228535
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2012
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Swaraj Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Kandhari  | Director | 21-Mar-2012 | Current |
| Pooja Kandhari | Director | 21-Mar-2012 | Current |
| Mathew Joseph | Director | 21-Mar-2012 | Current |
Financial Performance of Swaraj Formulations.
Swaraj Formulations Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 13.93% decrease. The company also saw a substantial fall in profitability, with a 57.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swaraj Formulations?
In 2015, Swaraj Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- The Greater Bombay Co-Op Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2014 | The Greater Bombay Co-Op Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Swaraj Formulations?
Swaraj Formulations has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swaraj Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swaraj Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
